BellyFlush Official Website › Disclaimer
BellyFlush Disclaimer: FDA, Medical And Results
These statements have not been evaluated by the Food and Drug Administration. BellyFlush is not intended to diagnose, treat, cure or prevent any disease. It is a dietary supplement, not a drug, and it is not FDA-approved. It is for healthy adults aged 18 and over. No trial of the finished product exists, and the research cited here concerns individual botanicals.
Five disclaimers, each with the reasoning behind it, rather than one paragraph of small print nobody reads.
The FDA disclaimer on BellyFlush
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
That sentence is required because BellyFlush makes structure and function claims. Detox and cleanse, gut and colon support, and reduced occasional bloating are all statements about how a product is intended to affect normal function, which is a different legal category from a claim to treat a condition.
No dietary supplement is FDA-approved. Supplements reach the market without pre-market approval of safety or effectiveness, which is a different regulatory route from medicines. The FDA-registered facility mark on the label describes a factory that has registered, which is a list rather than an inspection or an endorsement. the FDA explains the route in plain language.
The BellyFlush medical disclaimer
Nothing on this website is medical advice. It is general information about a supplement, written by a retail desk, and it cannot take account of your history, your medication or anything a clinician would find on examination.
Speak to a doctor or pharmacist before use if you take any prescription medicine, particularly a diuretic, a corticosteroid, digoxin, a blood thinner or a blood pressure medicine. Speak to one as well if you are pregnant or nursing, if you have a diagnosed bowel condition, or if you have abdominal pain that has not been assessed.
Stop and seek advice for sharp or localised pain, any rectal bleeding, vomiting, dizziness, muscle weakness or an irregular heartbeat. The last three can signal low potassium, which matters here because both the laxative botanicals and licorice root push in that direction. Penninkilampi 2017 quantified the licorice half of it.
Constipation that is new, persistent or accompanied by bleeding or weight change is a medical matter. the NIDDK and the joint AGA and ACG guideline are the right places to read before that conversation, and neither of them recommends starting with a herbal blend.
The BellyFlush results disclaimer
Individual results vary. Food, fibre, fluid, sleep and activity all affect what this product appears to do, and none of them is controlled on this website.
The star score, order count, recommend rate and reviewer roster published on the reviews page come from the distributor’s own record. They describe those individuals’ experiences. They are not typical results, they are not a promise that any particular person will experience the same thing, and they are not evidence.
The distributor supplies summary lines rather than review transcripts. Eight named reviewers share two sentences between them, and this website says so on the page rather than rendering them as eight testimonials. That disclosure is part of this disclaimer rather than separate from it.
What the BellyFlush references do and do not show
This website cites published research for each named botanical. Every citation was checked against its own record before it was written down, and the reference lists carry full citations and links rather than bare claims.
None of those studies tested BellyFlush. They tested individual ingredients, usually at a stated dose, usually alone, and frequently in a population with a diagnosed condition. A capsule that names an ingredient does not inherit the findings, and this website has been written specifically to avoid implying that it does.
The gap is widened by the missing amounts. Because no milligram figure is published for any of the eleven botanicals, there is no way to compare this product against any trial dose at all. Morishita 2021 used a stated quantity of senna. This label does not print one. That is the honest position and it appears on every page where research is cited.
Where a botanical has no controlled human trial behind it, this website says so rather than citing a laboratory paper as a substitute. Marshmallow root and bentonite clay are both described that way on the ingredients page.
The BellyFlush label transparency disclaimer
Eleven botanicals are named. No amount is published for any of them, on the bottle, on the listing artwork, or in the paperwork supplied to this desk. Neither is the extraction ratio for the two ingredients labelled as extracts, nor the sennoside content that would tell you how strongly the product acts.
This website prints “not published” in each of those places. It does not estimate, it does not infer a figure from a capsule size, and it does not describe the panel as transparent because the names are listed. Naming an ingredient and disclosing a dose are different things, and only the second one is a specification.
Two of the eleven, cascara sagrada and aloe, are named in the FDA's 2002 final rule as not generally recognized as safe and effective in over-the-counter laxative drug products, because the data requested were never submitted. That governs drug products rather than dietary supplements, so this capsule is lawful. Both halves of that appear on this website because leaving either one out would misrepresent it.
The BellyFlush commercial disclosure
This desk earns when somebody orders through this website. That is the commercial arrangement, it is stated on the about page as well, and no page here is written as though it were not true.
The pages that cost this desk money are the ones worth pointing at: the recommendation to buy one bottle first, the missing amounts, the published complaints, and the list of people who should not take this at all. An incentive disclosure is worth little on its own. What it is worth is the ability to check whether the site behaves as though the incentive governs it.
The BellyFlush imagery disclaimer
The photographs on this website come from the vendor art pack. Product shots show the bottle as supplied. Lifestyle and botanical images are marketing photography, and the quantity of plant material visible in a photograph has no relationship to the quantity inside a capsule.
One image in the pack shows a detox foot pad, which is a different product from a different line. It appears once, on the quality page, under a heading saying exactly that. BellyFlush is a capsule swallowed with water and nothing in this bottle is applied to skin.
Three further images in the pack are digital guide covers. The price ladder this desk works from lists no bonus with any pack, so those covers appear on the pricing page with that stated rather than in a bonus section that would imply an offer nobody made.
Sources cited on this BellyFlush page
Eight sources referred to in these disclaimers.
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements. https://www.fda.gov/food/information-consumers-using-dietary-supplements/questions-and-answers-dietary-supplements
- National Institutes of Health, Office of Dietary Supplements. Dietary Supplements: What You Need to Know. https://ods.od.nih.gov/factsheets/WYNTK-Consumer/
- National Institute of Diabetes and Digestive and Kidney Diseases. Treatment for Constipation. https://www.niddk.nih.gov/health-information/digestive-diseases/constipation/treatment
- Chang L, Chey WD, Imdad A, et al. American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation. Gastroenterology. 2023;164(7):1086-1106. https://pubmed.ncbi.nlm.nih.gov/37211380/
- Penninkilampi R, Eslick EM, Eslick GD. The association between consistent licorice ingestion, hypertension and hypokalaemia: a systematic review and meta-analysis. J Hum Hypertens. 2017;31(11):699-707. https://pubmed.ncbi.nlm.nih.gov/28660884/
- Morishita D, Tomita T, Mori S, et al. Senna Versus Magnesium Oxide for the Treatment of Chronic Constipation: A Randomized, Placebo-Controlled Trial. Am J Gastroenterol. 2021;116(1):152-161. https://pubmed.ncbi.nlm.nih.gov/32969946/
- U.S. Food and Drug Administration. Status of Certain Additional Over-the-Counter Drug Category II and III Active Ingredients. Final rule, 67 FR 31125, 9 May 2002. Aloe and cascara sagrada in OTC laxative drug products are not generally recognized as safe and effective. https://www.federalregister.gov/documents/2002/05/09/02-11510/status-of-certain-additional-over-the-counter-drug-category-ii-and-iii-active-ingredients
- National Center for Complementary and Integrative Health. “Detoxes” and “Cleanses”: What You Need To Know. https://www.nccih.nih.gov/health/detoxes-and-cleanses-what-you-need-to-know
Every page, every journal post, the bottle facts and the ingredients go through review by Alyssa Simpson, RDN before they ship. We write these pages from the BellyFlush label and this desk’s own order paperwork, cite published research for each named botanical, and print “not published” wherever a figure is not disclosed rather than estimating it. The seal beside this note names no clinician, and we treat it as a manufacturing statement rather than a medical endorsement. Corrections are made on the page and the review date moves forward. Write to [email protected]. Last reviewed September 2026 by Alyssa Simpson, RDN.
Order BellyFlush with the disclaimers read.
A supplement rather than a drug, no trial of the finished product, and a label that publishes no amounts.
$198 for six bottles, $33 each
Order BellyFlush On The Official WebsiteOne-time payment · no subscription · 365-day money-back guarantee · lot BEL-26/BE-3584